NanoDx

Led by Dr Ana Tukova, a biomolecular scientist specialising in nanosensor technology, NanoDx uses Raman-based nano-labelling to isolate and analyse circulating tumour cells within an hour, at just $13 per test.

This non-invasive approach replaces traditional tissue biopsies, giving clinicians immediate, personalised insights into cancer type and therapeutic targets.

NanoDx is advancing nanosensor technology, aiming to transform cancer diagnostics and expand this platform to a wide range of diseases, that are hard to diagnose on early stages.